| Date | Title | |
|---|---|---|
| 05/22/13 |
DANVERS, Mass., May 22, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director, Investor Relations and Corporate Development, will present at the Deutsche Bank 38th Annual Health Care Conference on Wednesday, May 29, 2013 at 2:50 p.m. E... |
|
| 05/17/13 |
DANVERS, Mass., May 17, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director, Investor Relations and Corporate Development, will present at the UBS Global Health Care Conference on Wednesday, May 22, 2013 at 10:00 a.m. ET. The confere... |
|
| 05/08/13 |
DANVERS, Mass., May 8, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director, Investor Relations and Corporate Development, will present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15, 2013 at 9:2... |
|
| 05/03/13 |
DANVERS, Mass., May 3, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director, Investor Relations and Corporate Development, will present at the Bank of America Merrill Lynch 2013 Smid Cap Conference on Tuesday, May 7, 2013 at 3:50 p.m.... |
|
| 05/02/13 |
DANVERS, Mass., May 2, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2013 revenue of $43.7 million, up 17% compared to revenue of $37.3 million in the same period of fiscal 2012, and fourth quarter fiscal 2013 GAAP net income of $3.7 million ... |
|
| 05/01/13 |
DANVERS, Mass., May 1, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced the publication of the PROTECT II Cost Effectiveness Study in the American Health & Drug Benefits (AHDB) journal, titled "A Value-Based Analysis of Hemodynamic Support Strategies for High-Risk H... |
|
| 04/17/13 |
DANVERS, Mass., April 17, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported preliminary fourth quarter fiscal 2013 revenue of $43.7 million, up 17% compared to revenue of $37.3 million in the same period of fiscal 2012, and up 14% compared to revenue of $38.3 million ... |
|
| 04/01/13 |
DANVERS, Mass., April 1, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced the enrollment of the first patient in RECOVER RIGHT, an Investigational Device Exemption (IDE) study of Impella® RP (Right Peripheral). The Impella RP is a percutaneous heart pump th... |
|
| 03/07/13 |
DANVERS, Mass., March 7, 2013 (GLOBE NEWSWIRE) -- Abiomed Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, notes that there will be over 15 Impella presentations in the scientific sessions at the annual American College of Cardiology (ACC) 2013 scientific meeting, scheduled from March 9 - 11, at the Moscone Convent... |
|
| 03/07/13 |
DANVERS, Mass., March 7, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director, Investor Relations and Corporate Development, will present at the Barclays Global Healthcare Conference on Thursday, March 14, 2013 at 9:00 a.m. ET. The co... |
|
| 03/04/13 |
Four Commercial Insurers Institute Broad Impella CoverageImpella Economic Study Published in The Journal of Managed Care Medicine (JMCM) DANVERS, Mass., March 4, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today provided a reimbursement update. Abiomed announced several re... |
|
| 02/27/13 |
DANVERS, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director, Investor Relations and Corporate Development, will present at the Cowen and Company 33rd Annual Health Care Conference on Wednesday, March 6, 2013 at 10:40... |
|
| 02/20/13 |
DANVERS, Mass., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that on February 19, 2013, Abiomed received a close-out letter from the Food and Drug Administration, Office of Compliance with respect to its previous FDA warning letter dated June 10, 2011. ... |
|
| 02/07/13 |
DANVERS, Mass., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Leerink Swann Global Healthcare Conference 2013 on Wednesday, February 13, 2013 at 8:00 a.m. ET. Th... |
|
| 02/06/13 |
DANVERS, Mass., Feb. 6, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2013 revenue of $38.3 million, up 19% compared to revenue of $32.2 million in the same period of fiscal 2012, on record quarterly patient usage, up 26% compared to the same ... |
|
| 01/17/13 |
DANVERS, Mass., Jan. 17, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD) announced today that on Wednesday, February 6, 2013, the Company will release financial results for the third quarter of fiscal 2013. The Company will host a conference call to discuss the results on Wednesday, February 6, 2013, at 8:00 a.m. ET. Michael R. Minogue, Chairm... |
|
| 12/06/12 |
DANVERS, Mass., Dec. 6, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that the U.S. Food and Drug Administration's (FDA) Circulatory System Devices Panel voted to retain Class III status for the temporary ventricular support devices within the non-roller type car... |
|
| 11/21/12 |
DANVERS, Mass., Nov. 21, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the 24th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28, 2012 at 8:00 a.m. EST. ... |
|
| 11/16/12 |
DANVERS, Mass., Nov. 16, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that a purported class action complaint was filed on November 16, 2012 in the United States District Court for the District of Massachusetts by Karse Simon and Arlene Simon, on behalf of thems... |
|
| 11/13/12 |
DANVERS, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that its Board of Directors has authorized a stock repurchase program of up to $15 million of its common stock. Abiomed will finance the stock repurchase program with available cash. The C... |
|
| 11/12/12 |
WASHINGTON, D.C. - The Advanced Medical Technology Association (AdvaMed) today launched MedicalTechnologyVeterans.org, a web portal that links job-seeking veterans to mentors and recruiters in the medical technology industry. The website is an extension of the Medical Technology Vete... |
|
| 11/12/12 |
DANVERS, Mass., Nov. 12, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, announced today that it received Investigational Device Exemption (IDE) approval from the Food & Drug Administration (FDA) for the use of the new Impella® RP (Right-side Percutaneous) in a pivotal clinic... |
|
| 11/09/12 |
DANVERS, Mass., Nov. 9, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director, Investor Relations and Corporate Development, will present at the 2012 Credit Suisse Annual Health Care Conference on Wednesday, November 14, 2012 at 4:30 p... |
|
| 11/07/12 |
DANVERS, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November 13, 2012 at 10:30 a.m.... |
|
| 11/02/12 |
DANVERS, Mass., Nov. 2, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, announced today that the Department of Health and Human Services, through the Centers for Medicare and Medicaid Services (CMS), has approved and released the valuation of the three new Category I Current Proce... |
|
| 11/01/12 |
Record GAAP Profitability of $5.5 Million or $0.13 Per Diluted Share DANVERS, Mass., Nov. 1, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported second quarter fiscal 2013 revenue of $37.4 million, up 27% compared to revenue of $29.5 million in the same period of fi... |
|
| 10/30/12 |
DANVERS, Mass., Oct. 30, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a ... |
|
| 10/30/12 |
DANVERS, Mass., Oct. 30, 2012 (GLOBE NEWSWIRE) -- In response to the effects of Hurricane Sandy on the East Coast and the related close of the trading markets, ... |
|
| 10/23/12 |
DANVERS, Mass., Oct. 23, 2012 (GLOBE NEWSWIRE) -- Abiomed,Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologie... |
|
| 10/15/12 |
DANVERS, Mass., Oct. 15, 2012 (GLOBE NEWSWIRE) -- Abiomed Inc. (Nasdaq:ABMD), a lead... |
|
| 10/11/12 |
DANVERS, Mass., Oct. 11, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD) ann... |
|
| 10/01/12 |
Boston—AdvaMed 2012: The MedTech Conference—October 1, 2012—The Advanced Medical Technology Association (AdvaMed) today announced the launch of the Medical Technology Veterans Program (MVP) Boot Camp for Returning Heroes, a year-long career tra... |
|
| 09/12/12 |
DANVERS, Mass., Sept. 12, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a... |
|
| 09/11/12 |
DANVERS, Mass., Sept. 11, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a... |
|
| 09/10/12 |
DANVERS, Mass., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a... |
|
| 09/06/12 |
DANVERS, Mass., Sept. 6, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:... |
|
| 09/04/12 |
DANVERS, Mass., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a... |
|
| 09/04/12 |
DANVERS, Mass., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a... |
|
| 08/02/12 |
DANVERS, Mass., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a ... |
|
| 07/12/12 |
DANVERS, Mass., July 12, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD) announced today that on Thursday, August 2, 2012, the Company will release financial results for the first quarter of fiscal... |
|
| 06/14/12 |
DANVERS, Mass., June 14, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of break-through heart support technologies, today announced it has received Health Canada approval to marke... |
|
| 06/13/12 |
DANVERS, Mass., June 13, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, Preside... |
|
| 05/31/12 |
DANVERS, Mass., May 31, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susie Lisa, Senior Director, Investor ... |
|
| 05/29/12 |
DANVERS, Mass., May 29, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, Presiden... |
|
| 05/16/12 |
DANVERS, Mass., May 16, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD - ... |
|
| 05/10/12 |
DANVERS, Mass., May 10, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susie Lisa, Senior Director, Investor ... |
|
| 05/08/12 |
DANVERS, Mass., May 8, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD) announced today that on Wednesday, May 16, 2012, the Company will release financial results for the fourth quarter and full ye... |
|
| 05/08/12 |
DANVERS, Mass., May 8, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of break-through heart support technologies, today announced its participation in three upcoming physician society meetin... |
|
| 05/01/12 |
DANVERS, Mass., May 01, 2012 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart ... |
|
| 04/12/12 |
DANVERS, Mass., Apr 12, 2012 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of break-through heart s... |
|
| 04/03/12 |
DANVERS, Mass.--(BUSINESS WIRE)--Apr. 3, 2012-- ... |
|
Investor Relations
Investor Tools
|
|
Print Page |
|
E-mail Page |
|
RSS Feeds |
|
Snapshot |